| 
May 15, 2007
BOORADY URGES SALE OF IN-HOUSE PBMs
Citigroup (New York) analyst Charles Boorady urged managed care companies to sell or spin off their in-house pharmacy benefit management operations, arguing that owning a PBM is “more ego than economics” and “not a key success factor for health insurers that can easily outsource the function.”
Subscribers: Click Here for the Full Story
Non-Subscribers: Click Here to Subscribe
Pay Per View ($75.00)
|
